Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial)

✍ Scribed by David J. Moliterno; Robert M. Califf; Frank V. Aguirre; Keaven Anderson; Kristina N. Sigmon; Harlan F. Weisman; Eric J. Topol; The EPIC Study Investigators

• Book ID: 113981746
• Publisher: Elsevier Science
• Year: 1995
• Tongue: English
• Weight: 459 KB
• Volume: 75
• Category: Article
• ISSN: 0002-9149
• DOI: 10.1016/s0002-9149(99)80616-x